Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q3 2019 Earnings
ALNY
6
Aug
Confirmed
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-2.43
-2.2
-1.96
-1.73
Details
Expected EPS
-2.02
Actual EPS
-1.93
Surprise EPS
0.09
Surprise Percent
+4.46%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.93 per share for Q3 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist